RxNorm 2105645 NDC Crossover
VITRAKVI 100 MG Oral Capsule
Related NDC Codes to RxNorm Concept 2105645
The following NDC codes crossover to the RxNorm Concept 2105645. This list is useful when crossing over from a given RxNorm code and the user is trying to choose a drug or product included in the NDC directory.
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Status | |
---|---|---|---|---|---|---|---|
50419-390 | Vitrakvi | Larotrectinib | Capsule | Oral | Bayer Healthcare Pharmaceuticals Inc. | ACTIVE | |
50419-391 | Vitrakvi | Larotrectinib | Capsule | Oral | Bayer Healthcare Pharmaceuticals Inc. | ACTIVE | |
50419-392 | Vitrakvi | Larotrectinib | Solution, Concentrate | Oropharyngeal | Bayer Healthcare Pharmaceuticals Inc. | ACTIVE | |
50419-393 | Vitrakvi | Larotrectinib | Solution, Concentrate | Oropharyngeal | Bayer Healthcare Pharmaceuticals Inc. | ACTIVE | |
71777-390 | Vitrakvi | Larotrectinib | Capsule | Oral | Loxo Oncology, Inc. | ACTIVE | |
71777-391 | Vitrakvi | Larotrectinib | Capsule | Oral | Loxo Oncology, Inc. | ACTIVE | |
71777-392 | Vitrakvi | Larotrectinib | Solution | Oral | Loxo Oncology, Inc. | ACTIVE |